We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.13%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
AUM
$5.1B
AUM Growth
+$1.47B
Cap. Flow
+$410M
Cap. Flow %
8.05%
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$102M
2
NVDA icon
NVIDIA
NVDA
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
GFS icon
GlobalFoundries
GFS
+$80.1M
5
MDLN
Medline Inc
MDLN
+$62.3M

Sector Composition

Rank Sector Weight
1 Industrials 29.61%
2 Miscellaneous 19.42%
3 Communication Services 10.49%
4 Technology 8.3%
5 Healthcare 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCLN
101
Lincoln International
LCLN
$896M
$5.97M 0.12%
+250,000
New +$5.9M
NHP
102
National Healthcare Properties
NHP
$1.19B
$5.86M 0.12%
+400,000
New +$5.6M
KOD icon
103
Kodiak Sciences
KOD
$2.42B
$5.84M 0.11%
+150,000
New +$5.84M
EROC
104
ERock Inc
EROC
$629M
$5.8M 0.11%
+400,000
New +$6.37M
CELC icon
105
Celcuity
CELC
$4.41B
$5.75M 0.11%
+55,000
New +$6.35M
MP icon
106
MP Materials
MP
$10.3B
$5.6M 0.11%
100,000
HAWK
107
HawkEye 360 Inc
HAWK
$2.01B
$5.56M 0.11%
+275,000
New +$7.6M
SRRK icon
108
Scholar Rock
SRRK
$7.16B
$5.5M 0.11%
+100,000
New +$4.83M
KPET
109
KPET Ultra Paceline Corp
KPET
$290M
$5.49M 0.11%
+550,000
New +$5.51M
VERA icon
110
Vera Therapeutics
VERA
$2.43B
$5.36M 0.11%
+125,000
New +$4.66M
PMTR
111
Perimeter Acquisition Corp I
PMTR
$321M
$5.21M 0.1%
500,000
EA
112
DELISTED
Electronic Arts
EA
$5.17M 0.1%
25,200
AADX
113
Applied Aerospace & Defense Inc
AADX
$2.44B
$5.13M 0.1%
+225,000
New +$4.42M
CLBR
114
Colombier Acquisition Corp III
CLBR
$410M
$5.13M 0.1%
500,000
OBA
115
Oxley Bridge Acquisition Ltd
OBA
$5.12M 0.1%
500,000
SMMT icon
116
Summit Therapeutics
SMMT
$10.9B
$5.1M 0.1%
+350,000
New +$6.21M
IACQU
117
Irenic Acquisition Corp Unit
IACQU
$5.08M 0.1%
+500,000
New +$5.03M
ADAC
118
American Drive Acquisition Co
ADAC
$290M
$5.01M 0.1%
500,000
RARE icon
119
Ultragenyx Pharmaceutical
RARE
$2.55B
$5.01M 0.1%
+150,000
New +$3.73M
EYPT icon
120
EyePoint Inc
EYPT
$387M
$5M 0.1%
+350,000
New +$4.68M
LPCV
121
Launchpad Cadenza Acquisition Corp I
LPCV
$288M
$4.99M 0.1%
500,000
HCIC
122
Hennessy Capital Investment Corp
HCIC
$355M
$4.96M 0.1%
+500,000
New +$4.94M
QADR
123
QDRO Acquisition Corp
QADR
$250M
$4.96M 0.1%
+500,000
New +$4.95M
CURB
124
Curbline Properties
CURB
$3.47B
$4.93M 0.1%
+162,074
New +$4.63M
YSS
125
York Space Systems
YSS
$1.28B
$4.92M 0.1%
200,000
-207,837
-51% -$6.45M

Similar funds

Ghisallo Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.

  • Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
  • Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
  • Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
  • Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
  • Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
  • Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
  • Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.